UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Gut, 2003-03, Vol.52 (3), p.420-424

2003

Volltextzugriff (PDF)

HLA-DRB11301 AND 1302 protect against chronic hepatitis B

Journal of hepatology, 1997-03, Vol.26 (3), p.503-507

1997

Volltextzugriff (PDF)

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis

Virchows Archiv : an international journal of pathology, 1997-08, Vol.431 (2), p.119-124

1997

Volltextzugriff (PDF)

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

Hepatology (Baltimore, Md.), 2000-02, Vol.31 (2), p.521-527

2000

Volltextzugriff (PDF)

Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin‐12

Clinical and experimental immunology, 2002-10, Vol.130 (1), p.107-114

2002

Volltextzugriff (PDF)

Regulation of the neutralizing anti‐hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection

Clinical and experimental immunology, 1996-07, Vol.105 (1), p.52-58

1996

Volltextzugriff (PDF)

Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B

The Journal of infectious diseases, 1993-11, Vol.168 (5), p.1133-1139

1993

Volltextzugriff (PDF)

HBV‐specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro‐ and anti‐inflammatory cytokines

Clinical and experimental immunology, 1999-03, Vol.115 (3), p.508-514

1999

Volltextzugriff (PDF)

Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma

Hepatology (Baltimore, Md.), 1999-01, Vol.29 (1), p.238-244

1999

Volltextzugriff (PDF)

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C

Journal of medical virology, 2001-07, Vol.64 (3), p.340-349

2001

Volltextzugriff (PDF)

Individual and Common Antigen‐Recognition Sites of Liver‐Derived T Cells in Patients with Autoimmune Hepatitis

Scandinavian journal of immunology, 2003-04, Vol.57 (4), p.384-390

2003

Volltextzugriff (PDF)

Retrospektive Kohortenstudie zur Lamivudintherapie bei Patienten mit chronischer Hepatitis B

Deutsche medizinische Wochenschrift, 2001, Vol.126 (5), p.97-102

2001

Volltextzugriff (PDF)

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trimera mouse

Hepatology (Baltimore, Md.), 2000-02, Vol.31 (2), p.480-487

2000

Volltextzugriff (PDF)

The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome

Journal of hepatology, 1998-10, Vol.29 (4), p.524-532

1998

Volltextzugriff (PDF)

The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response

Journal of hepatology, 1999-03, Vol.30 (3), p.353-358

1999

Volltextzugriff (PDF)

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis

Journal of hepatology, 1999-10, Vol.31 (4), p.635-640

1999

Volltextzugriff (PDF)

Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-α plus ribavirin

European journal of clinical investigation, 2003-07, Vol.33 (7), p.628-629

2003

Volltextzugriff (PDF)

Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients

Zeitschrift für Gastroenterologie, 1995-09, Vol.33 (9), p.527

1995

Volltextzugriff (PDF)

Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-α

European journal of cancer (1990), 1995-12, Vol.31 (13), p.2427-2428

1995

Volltextzugriff (PDF)

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B

Journal of medical virology, 2002-04, Vol.66 (4), p.452-460

2002

Volltextzugriff (PDF)

Autoimmunhepatitis und Overlap-Syndrom: Therapie

Praxis (Bern. 1994), 2002-08, Vol.91 (34), p.1347-1351

Löhr

2002

Volltextzugriff (PDF)

Antigen-independent in vitro expansion of T cells does not affect the T cell receptor Vβ repertoire

Journal of molecular medicine (Berlin, Germany), 1997-09, Vol.75 (9), p.678-686

1997

Volltextzugriff (PDF)

Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells

Journal of medical virology, 1998-10, Vol.56 (2), p.112-117

1998

Volltextzugriff (PDF)

HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-α

Journal of medical virology, 1995-08, Vol.46 (4), p.314-320

1995

Volltextzugriff (PDF)

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

Journal of hepatology, 1999-09, Vol.31 (3), p.407-415

1999

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(73)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Science & Technology
(54)
Life Sciences & Biomedicine
(51)
Biological And Medical Sciences
(38)
Medical Sciences
(35)
Adult
(29)
Male
(29)
Female
(28)
Gastroenterology & Hepatology
(28)
Middle Aged
(25)
Infectious Diseases
(19)
Human Viral Diseases
(18)
Viral Diseases
(18)
Viral Hepatitis
(17)
Aged
(16)
T-Lymphocytes - Immunology
(11)
Interferon-Alpha - Therapeutic Use
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(9)
Antiviral Agents - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

HLA-DRB11301 AND 1302 protect against chronic hepatitis B

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin‐12

Regulation of the neutralizing anti‐hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection

Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B

HBV‐specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro‐ and anti‐inflammatory cytokines

Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C

Individual and Common Antigen‐Recognition Sites of Liver‐Derived T Cells in Patients with Autoimmune Hepatitis

Retrospektive Kohortenstudie zur Lamivudintherapie bei Patienten mit chronischer Hepatitis B

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trimera mouse

The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome

The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis

Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-α plus ribavirin

Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients

Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-α

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B

Autoimmunhepatitis und Overlap-Syndrom: Therapie

Antigen-independent in vitro expansion of T cells does not affect the T cell receptor Vβ repertoire

Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells

HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-α

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

Suchergebnisse filtern